Bioventus Inc. (BVS) DCF Valuation

Bioventus Inc. (BVS) DCF Valuation

US | Healthcare | Medical - Devices | NASDAQ
Bioventus Inc. (BVS) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Bioventus Inc. (BVS) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of Bioventus Inc.? Our BVS DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 340.1 321.2 430.9 512.1 512.3 573.2 641.2 717.3 802.5 897.7
Revenue Growth, % 0 -5.58 34.17 18.85 0.04452108 11.87 11.87 11.87 11.87 11.87
EBITDA 61.6 50.4 51.8 -109.2 -23.1 22.9 25.7 28.7 32.1 35.9
EBITDA, % 18.11 15.71 12.02 -21.32 -4.5 4 4 4 4 4
Depreciation 30.3 28.6 38.7 61.4 57.4 57.3 64.1 71.7 80.2 89.8
Depreciation, % 8.91 8.92 8.98 11.99 11.2 10 10 10 10 10
EBIT 31.3 21.8 13.1 -170.6 -80.4 -34.4 -38.5 -43.0 -48.1 -53.8
EBIT, % 9.19 6.79 3.05 -33.31 -15.7 -6 -6 -6 -6 -6
Total Cash 64.5 86.8 43.9 31.8 37.0 79.8 89.3 99.9 111.8 125.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 85.1 88.3 125.0 136.6 123.0
Account Receivables, % 25.03 27.49 29.02 26.67 24.02
Inventories 27.3 29.1 61.7 85.4 91.3 75.6 84.5 94.6 105.8 118.4
Inventories, % 8.03 9.07 14.32 16.68 17.83 13.18 13.18 13.18 13.18 13.18
Accounts Payable 6.4 4.4 16.9 36.7 23.0 21.6 24.2 27.1 30.3 33.9
Accounts Payable, % 1.89 1.38 3.93 7.17 4.5 3.77 3.77 3.77 3.77 3.77
Capital Expenditure -8.3 -20.7 -7.4 -11.5 -7.4 -16.4 -18.3 -20.5 -22.9 -25.6
Capital Expenditure, % -2.45 -6.44 -1.71 -2.25 -1.44 -2.86 -2.86 -2.86 -2.86 -2.86
Tax Rate, % -29 -29 -29 -29 -29 -29 -29 -29 -29 -29
EBITAT 22.1 22.5 16.5 -138.0 -103.8 -31.0 -34.7 -38.9 -43.5 -48.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -61.9 23.5 -9.0 -103.5 -59.8 -4.3 -13.3 -14.9 -16.7 -18.7
WACC, % 8.11 9.24 9.24 8.5 9.24 8.86 8.86 8.86 8.86 8.86
PV UFCF
SUM PV UFCF -50.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -19
Terminal Value -277
Present Terminal Value -181
Enterprise Value -232
Net Debt 358
Equity Value -590
Diluted Shares Outstanding, MM 63
Equity Value Per Share -9.42

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Bioventus Inc.’s (BVS) financial data pre-filled to streamline your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life BVS Financials: Pre-filled historical and projected data for Bioventus Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Bioventus’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Bioventus’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Bioventus Inc. (BVS) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Bioventus Inc. (BVS)’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Bioventus Inc. (BVS)?

  • Innovative Solutions: Benefit from cutting-edge technologies in regenerative medicine.
  • Proven Efficacy: Our products are backed by extensive clinical research and positive outcomes.
  • Patient-Centric Approach: Focused on improving patient quality of life through advanced therapies.
  • Expert Support: Access to a dedicated team of professionals for guidance and assistance.
  • Commitment to Excellence: We prioritize quality and compliance in all our offerings.

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions regarding Bioventus Inc. (BVS) stock transactions.
  • Financial Analysts: Enhance valuation methodologies with accessible financial models tailored for Bioventus Inc. (BVS).
  • Consultants: Provide clients with accurate and timely valuation assessments related to Bioventus Inc. (BVS).
  • Business Owners: Learn from the valuation strategies of Bioventus Inc. (BVS) to inform your own business decisions.
  • Finance Students: Explore real-world valuation techniques using Bioventus Inc. (BVS) data and case studies.

What the Template Contains

  • Pre-Filled Data: Includes Bioventus Inc.'s (BVS) historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations tailored for Bioventus Inc. (BVS).
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs specific to Bioventus Inc. (BVS).
  • Key Financial Ratios: Analyze Bioventus Inc.'s (BVS) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease for Bioventus Inc. (BVS).
  • Clear Dashboard: Charts and tables summarizing key valuation results for Bioventus Inc. (BVS).

Es wurden keine passenden Produkte gefunden.